THE TYPE OF HEPARIN USED FOR ANTICOAGULATION IN PATIENTS ON HEMODIALYSIS AFFECTS CARNITINE METABOLISM

https://storage.unitedwebnetwork.com/files/1099/6f53e33e051ba0c8083d3c43600a7679.pdf
THE TYPE OF HEPARIN USED FOR ANTICOAGULATION IN PATIENTS ON HEMODIALYSIS AFFECTS CARNITINE METABOLISM
Kie
Sekiguchi
Takaya Abe takayabe@athena.ocn.ne.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Ei Shiomi eishiomi@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Daiki Ikarashi dikara@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Tomohiko Matsuura tomohiko.matsuura.net@gmail.com Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Shigekatsu Maekawa maekawa@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Renpei Kato rekato@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Mitsugu Kanehira mkanehir@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Ryo Takata rtakata@iwate-med.ac.jp Iwate Medical University Medical education Shiwa-gun, Yahaba-cho
Jun Sugimura jsugi@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho
Takashi Sekiguchi tsekiguchi@koujin-kai.com Sekiguchi Internal Clinic Nephrology Hachinohe
Wataru Obara watao@iwate-med.ac.jp Iwate Medical University Urology Shiwa-gun, Yahaba-cho